Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.

M.J. Verhaar - Langereis; A. Karakus; M.A. van Eijkeren; E.E. Voest; P.O. Witteveen

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.

Translated title of the contribution: Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.

M.J. Verhaar - Langereis
, A. Karakus
, M.A. van Eijkeren
, E.E. Voest
, P.O. Witteveen

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.
Original language	Undefined/Unknown
Pages (from-to)	65-70
Number of pages	6
Journal	International Journal of Gynaecological Cancer
Volume	16
Issue number	1
Publication status	Published - 2006

Cite this

@article{647ffe8533a744bf8ef5a6a14e9c3880,

title = "Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.",

author = "\{Verhaar - Langereis\}, M.J. and A. Karakus and \{van Eijkeren\}, M.A. and E.E. Voest and P.O. Witteveen",

year = "2006",

language = "Undefined/Unknown",

volume = "16",

pages = "65--70",

journal = "International Journal of Gynaecological Cancer",

issn = "1048-891X",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer.

AU - Verhaar - Langereis, M.J.

AU - Karakus, A.

AU - van Eijkeren, M.A.

AU - Voest, E.E.

AU - Witteveen, P.O.

PY - 2006

Y1 - 2006

M3 - Article

SN - 1048-891X

VL - 16

SP - 65

EP - 70

JO - International Journal of Gynaecological Cancer

JF - International Journal of Gynaecological Cancer

IS - 1

ER -